Introduction
The morbidity and mortality of lung cancer rank first among all the malignant tumors worldwide [
1]. Although significant progress has been made in tumor screening and treatment in recent years, the 5-year survival rate for lung cancer has not improved significantly [
2]. Lung adenocarcinoma (LUAD), accounting for 50% of all lung cancer cases, is the most common subtype of non-small cell lung cancer (NSCLC) [
3]. Therefore, an in-depth study of the pathogenesis of LUAD is essential for the development of its biomarkers and the improvement of the detection and survival rate of LUAD patients.
NEDD4 family belongs to the E3 ubiquitin ligase subfamily, which contains nine members: NEDD4, NEDD4L, WWP1, WWP2, HECW1, HECW2, SMURF1, SMURF2, and ITCH. NEDD4-like proteins can target cell cycle and apoptosis-related proteins and regulate various biological processes of cells [
4]. Previous studies have shown that NEDD4-like proteins can regulate TGFβ, Notch, Hedgehog, Hippo, Wnt, Raf/ MEK/ERK, and PTEN/PI3K/Akt signaling pathways, which play key roles in the occurrence and development of carcinomas [
5]. NEDD4 was confirmed to mediate cell migration signaling of EGFR in lung cancer [
6]. NEDD4L was reported to inhibit TGFβ induced epithelial to mesenchymal transition (EMT) and be related to the prognosis of lung cancer patients [
7,
8]. WWP1 induces the ubiquitination of EGFR at Lys689, which enhances EGFR recycling in lung cancer [
9]. WWP2 promotes the proliferation of lung cancer cells by mediating p27 ubiquitination [
10]. SMURF1 regulates lung cancer proliferation and migration by mediating PIPKIγ ubiquitination [
11]. SMURF2 acts as a negative regulator of TGFβ signaling by ubiquitin-mediated degradation of TGFβR1 in lung cancer [
12]. HECW1 promotes the metastasis of NSCLC by mediating the ubiquitination of Smad4 [
13]. Li et al. reported that inhibition of ITCH could suppress proliferation and induce apoptosis of lung cancer cells [
14]. The function of HECW2 in lung cancer is still unclear. NEDD4 family members play an important role in the biological process of lung cancer, but their function and mechanism in LUAD still need to be further explored.
EGFR is the key driver of lung cancer. EGFR signaling network plays a vital role in the maintenance and growth of epithelial tissues [
15]. EGFR signaling pathway is involved in the regulation of lung cancer cell proliferation, migration, invasion, apoptosis, and other biological processes [
16‐
18]. mTOR is another key oncogene in carcinomas. Activated mTOR signaling regulates protein synthesis, survival, and cell growth by downstream effectors P70S6K, 4ebp1, and eIF4 [
19]. Insulin inhibits TSC2 by activating Akt and releases the inhibitory effect of the latter on Rheb, thereby activating mTOR [
20]. In addition, PI3K Signaling also regulates mTORC1 through Rheb [
21]. However, the activity of the PI3K/Akt pathway is regulated by EGFR. Due to the limited role of TSC2 in lung adenocarcinoma, EGFR should be able to regulate mTOR activity in other ways. Deng et al. reported that ubiquitin ligases RNF152 and USP4 play a vital role in Rheb-mediate mTORC1 activation [
22]. Hong's study showed that CBLC enhanced EGFR dysregulation and signaling in LUAD [
23].
Cumulative evidence indicates that ubiquitin ligase is related to the EGFR signal and the mTOR pathway. However, the role of the NEDD4 family in LUAD remains unclear and needs to be further studied.
In this study, we probed the expression of NEDD4 family members in LUAD via bioinformatics analyses and found that NEDD4L was down-regulated and associated with poor prognosis. Subsequently, we confirmed that EGFR enhanced mTOR signaling activity by down-regulating NEDD4L, thereby promoting the proliferation of LUAD.
This study is first to reveal the mechanism of EGFR/NEDD4L/mTOR signal axis, and provided a new potential target for the treatment of LUAD.
Materials and methods
Data acquisition and processing
Online database analysis
A meta-analysis of NEDD4L transcriptional level in LUAD was performed by the Oncomine database (
https://www.oncomine.org/resource/login.html). NEDD4L expression data of 9 groups of LUAD and normal tissues were retrieved and compared statistically. The default threshold was as follows: P < 1E−4, fold change > 2, and the top 10% of genes. The GEPIA database (
http://gepia.cancer-pku.cn/index.html) was used to analyze the correlation between NEDD4L expression level and prognosis of LUAD patients.
Cell culture and treatment
Human LUAD cancer H1299 and PC9 cells were obtained from Cell Bank of Shanghai Institute for Biological Sciences, Chinese Academy of Sciences. Cells were cultured in RPMI 1640 (H1299), DMEM (PC9) medium, containing 10% FBS, and maintained in an incubator with constant temperature and CO2. Cells were treated with gefitinib (ZD1839, Selleck).
Transfection and lentiviral transduction
Transfection was performed using Lipo8000™ (C0533, Beyotime). The siRNAs were acquired from GenePharma Company (Shanghai, China). The siRNA sequences are as follows: siEGFR#1, 5′-GUCCGCAAGUGUAAGAAGUTT-3′; siEGFR#2, 5′-GGAGAUAAGUGAUGGAGAUTT-3′; negative control, 5′-UUCUCCGAACGUGUCACGUTT-3′. The lentivirus was acquired from Genechem company (Shanghai, China).
The target sequence of shNEDD4L is as follow: 5′-GGAACUAAGCAGAAGGCUUTT-3′. The method of lentivirus transfection of cells was described in our previous study [
25].
CCK-8 assay
The cells were placed in 96 well plates and detected at 24, 48, and 72 h by Cell Counting Kit-8 (Beyotime C0038, China) [
26]. The cell culture medium and CCK-8 reagent were prepared into working solution according to 10:1. Remove the residual medium and add 100 μL working solution, incubate at 37℃ for 1 h, and detect with enzyme labeling instrument (Biorad 680, USA).
The PC9 cells were seeded onto 6-well plates (200 cells/well) and cultured for 14 days. Cells were fixed using paraformaldehyde and stained using crystal violet as described in our previous study [
26]. Each group had three repetitions, and the t-test was used to analyze the difference in clone number between groups.
Cell cycle assay
Cells were first starved in 1% FBS medium for 12 h, then spread onto 6-well plates and cultured in complete medium for 24 h. Cells were treated using a cell cycle and apoptosis analysis kit (C1052, Beyotime) and detected using flow cytometry. The difference between groups was detected by t-test.
Gene set enrichment analysis
Patients from the TCGA_LUAD dataset were divided into high-expression and low-expression subgroups according to NEDD4L expression level. Gene set enrichment analysis (GSEA) was performed to investigate pathways enriched in the high-expression and low-expression subgroups. C2.cp.k
egg.v7.1.symbols.gmt was chosen as the gene set database. Signaling pathways that meet the following criteria can be significantly enriched: nominal p-value < 0.05, q-value < 0.25, and normalized enrichment score > 1 [
27].
Western blotting
Cells were lysed on ice with pre-cooled RIPA for 10 min, and centrifuged at 4 °C for 10 min (12,000 rpm/min) to obtain the supernatant for subsequent detection. Western blotting was performed using antibodies against EGFR (#4267S, CST), phospho-EGFR (#3777, CST), mTOR (#2983, CST), phospho-mTOR (ab109268, Abcam), NEDD4L (ab46521, Abcam), and S6K (ab186753, Abcam), phospho-S6K (ab131436, Abcam), β-Actin (#3700, CST). Horseradish peroxidase-labeled Goat anti-rabbit IgG (H + L) (A0208, Beyotime) was used as secondary antibodies.
Patients and specimens
Twenty-four pairs of human LUAD tissues and para-carcinoma tissues were obtained from patients at Shanxi Provincial People's Hospital (Taiyuan, China). The use of clinical specimens was approved by the Ethics Committee of Zhoukou Normal University (ZKNU-2019043).
Immunohistochemistry and immunofluorescence assay
The carcinoma tissues and para-carcinoma tissues were fabricated into a tissue chip. Immunohistochemical (IHC) staining of FFPE sections was performed as described [
26]. The expression of target genes was assessed by the H-score system, and the formula for the H-score is as follows: Histoscore = Σ (I × Pi), where I = intensity of staining and Pi = percentage of stained tumor cells [
28]. Cells were seeded onto the special dish for laser confocal scanning, and the density was about 30%. Cells were treated with 10 μM gefitinib for 24 h. Immunofluorescence was performed as described in our previous study [
26].
Xenograft lung adenocarcinoma model
For the xenograft lung cancer models, 6-week-old BALB/c nude mice were obtained from Weitong Lihua Experimental Animal Technology Co., Ltd (Beijing, China). H1299 cells (5 × 106 per mouse) were injected subcutaneously into the right side of mice, and the tumor volumes were measured 7 days later (Day 0). We measured the tumor volume every three days, and the formula is as follows: volume = (length*width2)/2. On day 18 of tumor development, mice were sacrificed and tumors were isolated and subjected to IHC analysis. All animal experiments were approved by the Ethics Committee of Zhoukou Normal University (ZKNU-2019043).
Statistical analysis
Correlation analysis was conducted by GraphPad Prism (version 8.0.1) with the Pearson method. The IHC score difference analysis was also conducted by GraphPad Prism software using paired t-test. The prognosis of LUAD patients from different subgroups was compared using the Kaplan–Meier method with a log-rank test. Target genes expression from different groups was compared by R software (version 4.0.2) using the Wilcox test. The “pheatmap”, "ggplot2", "ggpubr", "survival", "survminer", "plyr", "grid", and "gridExtra" packages in R (version 4.0.2) were used for visualization. A p-value of less than 0.05 was considered to be statistically significant (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
Discussion
NEDD4 family ubiquitin ligases, as the key regulators of cell surface receptor signaling, play a key role in the development and progression of tumors [
30,
31]. In addition, NEDD4-like proteins have high substrate specificity, which makes them potentially suitable targets for tumor therapy [
32]. However, the detailed role of NEDD4-like proteins in LUAD pathogenesis is still unclear. Here, our integrated bioinformatics analysis demonstrated a prognostic value of NEDD4L in LUAD, which was consistent with the results observed by Yang et al. in lung cancer [
8]. GSEA results indicated that genes regulated by NEDD4L were enriched in the mTORC1 pathway (Fig.
3A, B). Subsequently, we knocked down or overexpressed NEDD4L in LUAD cells and measured the activity of the mTOR pathway. The results suggested that NEDD4L played a critical role in the regulation of the mTOR pathway, which was consistent with Chelly's study [
33]. To confirm the reliability of the conclusion, IHC was performed using human LUAD tissues and mouse xenograft tumor tissues, and which showed that NEDD4L expression level was significantly negatively correlated with p-mTOR and p-S6K (Figs.
4D, E,
7I, J). The mTOR pathway plays a decisive role in cell proliferation, survival, and metabolism, which suggests that NEDD4L may be related to the development of LUAD [
34]. Wang et al. showed that NEDD4L suppressed proliferation and migration of NSCLC [
35]. Our results of in vitro and in in vivo experiments indicated that NEDD4L inhibited the proliferation of LUAD by inducing S phase arrest (Figs.
2,
7A–H). Together, these results suggest that NEDD4L acted as a tumor suppressor gene in LUAD.
EGFR signaling is associated with the malignant behaviors of lung cancer and drives uncontrolled cell growth and invasion [
36]. However, it remains to be fully characterized how EGFR signaling regulates target genes and drives the development of LUAD. We found that the levels of total and phosphoryltaed EGFR were negatively correlated with the expression of NEDD4L in LUAD tissues (Fig.
5). The results of our in vitro experiments indicated that EGFR inhibited the expression of NEDD4L in LUAD cells (Fig.
6). However, bioinformatics analysis showed that EGFR was positively correlated to NEDD4L in normal tissues (Additional file
2: Fig. S2). The abnormal activation of EGFR signaling in LUAD may lead to changes in the expression or activity of a cohort of transcription factors like SP1 [
37], AP-1 [
38] and CREB [
39], all of which were documented to that regulate NEDD4L expression. Further investigations are needed to define the mechanism underlying transcriptional regulation of NEDD4L by EGFR in LUAD cells.
Understanding the complicated cross-talk between different signaling pathways during tumorigenesis will contribute to the development of new methods and new targets for tumor therapy. The mTOR and EGFR signaling pathways are crucial for LUAD. However, whether they synergistically promote carcinogenesis or whether there is an interplay between these canonical pathways in lung cancer is still unclear. Kumar et al
. showed that the mTOR‑Rictor‑EGFR axis played a vital role in glioblastoma [
40]. Cui et al
. reported that EGFR promoted tumor proliferation and angiogenesis by activating the PI3K-AKT-mTOR and RAF-MEK-ERK pathways in hepatocellular carcinoma [
41]. Interestingly, in this study, we found that NEDD4L could act as a bridge between EGFR and mTOR pathways. Combining the existing literature and our findings, we propose that the EGFR-NEDD4L-mTOR axis plays a vital role in thedevelopment of LUAD, suggesting a prognostic role of NEDD4L in EGFR-driven lung malignancy as well as the applicability of combined EGFR and mTOR targeting in LUAD therapy.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.